Autor: "Thiébaut, Rodolphe" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy.
Autorzy:: Lhomme E; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.; Université Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.; CHU de Bordeaux, Pôle de santé publique, Bordeaux, France.; INRIA SISTM, Talence, France.; Vaccine Research Institute (VRI), Créteil, France.
Richert L; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.; Université Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.; CHU de Bordeaux, Pôle de santé publique, Bordeaux, France.; INRIA SISTM, Talence, France.; Vaccine Research Institute (VRI), Créteil, France.
Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States of America.; HIV Vaccine Trials Network, Seattle, Washington, 98109, United States of America.
Pasin C; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.; Université Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.; INRIA SISTM, Talence, France.
Kalams SA; Infectious Diseases Unit, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, 37232, United States of America.
Morgan C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States of America.; HIV Vaccine Trials Network, Seattle, Washington, 98109, United States of America.
Self S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States of America.; HIV Vaccine Trials Network, Seattle, Washington, 98109, United States of America.
De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States of America.; HIV Vaccine Trials Network, Seattle, Washington, 98109, United States of America.
Thiébaut R; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.; Université Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France.; CHU de Bordeaux, Pôle de santé publique, Bordeaux, France.; INRIA SISTM, Talence, France.; Vaccine Research Institute (VRI), Créteil, France.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2016 Apr 28; Vol. 11 (4), pp. e0152952. Date of Electronic Publication: 2016 Apr 28 (Print Publication: 2016).
Typ publikacji:: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms:: AIDS Vaccines/*immunology
CD4-Positive T-Lymphocytes/*immunology
CD8-Positive T-Lymphocytes/*immunology
HIV Infections/*immunology
HIV-1/*immunology
Adenoviridae/immunology ; Adolescent ; Adult ; Antibodies, Viral/immunology ; DNA, Recombinant/immunology ; Genetic Vectors/immunology ; Humans ; Immunization, Secondary/methods ; Interferon-gamma/immunology ; Interleukin-2/immunology ; Middle Aged ; Vaccination/methods ; Vaccines, DNA/immunology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity.
Autorzy:: Brezar V; Equipe 16, Inserm U955, Créteil, France; Faculté de médecine, Université Paris Est, Créteil, France; Vaccine Research Institute (VRI), Créteil, France.
Ruffin N; Equipe 16, Inserm U955, Créteil, France; Faculté de médecine, Université Paris Est, Créteil, France; Vaccine Research Institute (VRI), Créteil, France.
Richert L; Vaccine Research Institute (VRI), Créteil, France; Université Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; CHU de Bordeaux, Pôle de santé publique, Bordeaux, France; INRIA SISTM, Talence, France.
Surenaud M; Equipe 16, Inserm U955, Créteil, France; Faculté de médecine, Université Paris Est, Créteil, France; Vaccine Research Institute (VRI), Créteil, France.
Lacabaratz C; Equipe 16, Inserm U955, Créteil, France; Faculté de médecine, Université Paris Est, Créteil, France; Vaccine Research Institute (VRI), Créteil, France.
Palucka K; Ralph M. Steinman Center for Cancer Vaccines, Baylor Institute for Immunology Research, Baylor Research Institute, Dallas, Texas, United States of America; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, United States of America.
Thiébaut R; Vaccine Research Institute (VRI), Créteil, France; Université Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; CHU de Bordeaux, Pôle de santé publique, Bordeaux, France; INRIA SISTM, Talence, France.
Banchereau J; Equipe 16, Inserm U955, Créteil, France; Faculté de médecine, Université Paris Est, Créteil, France; Vaccine Research Institute (VRI), Créteil, France; Ralph M. Steinman Center for Cancer Vaccines, Baylor Institute for Immunology Research, Baylor Research Institute, Dallas, Texas, United States of America; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, United States of America.
Levy Y; Equipe 16, Inserm U955, Créteil, France; Faculté de médecine, Université Paris Est, Créteil, France; Vaccine Research Institute (VRI), Créteil, France; Service d'immunologie clinique et maladies infectieuses, AP-HP, Hôpital H. Mondor-A. Chenevier, Créteil, France.
Seddiki N; Equipe 16, Inserm U955, Créteil, France; Faculté de médecine, Université Paris Est, Créteil, France; Vaccine Research Institute (VRI), Créteil, France.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2015 Mar 27; Vol. 11 (3), pp. e1004752. Date of Electronic Publication: 2015 Mar 27 (Print Publication: 2015).
Typ publikacji:: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: AIDS Vaccines/*administration & dosage
Dendritic Cells/*immunology
HIV-1/*immunology
Interferon-gamma/*immunology
T-Lymphocytes, Regulatory/*immunology
AIDS Vaccines/immunology ; Adult ; Female ; Humans ; Male ; Middle Aged ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Quantifying and predicting the effect of exogenous interleukin-7 on CD4+ T cells in HIV-1 infection.
Autorzy:: Thiébaut R; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; Univ. Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; INRIA, SISTM team, Bordeaux, France.
Drylewicz J; Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands; Theoretical Biology and Bioinformatics, Department of Biology, Utrecht University, Utrecht, The Netherlands.
Prague M; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; Univ. Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; INRIA, SISTM team, Bordeaux, France.
Lacabaratz C; INSERM, Unité U955, Créteil, France; Université Paris-Est, Faculté de Médecine, UMR-S955 Creteil, France.
Beq S; CYTHERIS, Issy Les Moulineaux, France.
Jarne A; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; Univ. Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; INRIA, SISTM team, Bordeaux, France.
Croughs T; CYTHERIS, Issy Les Moulineaux, France.
Sekaly RP; Vaccine and Gene Therapy Institute-Florida, Port St. Lucie, Florida, United States of America.
Lederman MM; Case Western Reserve University/University Hospitals/Case Medical Center, Cleveland, Ohio, United States of America.
Sereti I; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Commenges D; INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; Univ. Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; INRIA, SISTM team, Bordeaux, France.
Lévy Y; INSERM, Unité U955, Créteil, France; Université Paris-Est, Faculté de Médecine, UMR-S955 Creteil, France; AP-HP, Groupe Henri-Mondor Albert-Chenevier, Immunologie Clinique, Creteil, France.; Pokaż więcej
Źródło:: PLoS computational biology [PLoS Comput Biol] 2014 May 22; Vol. 10 (5), pp. e1003630. Date of Electronic Publication: 2014 May 22 (Print Publication: 2014).
Typ publikacji:: Journal Article
MeSH Terms:: Models, Immunological*
CD4-Positive T-Lymphocytes/*immunology
HIV Infections/*immunology
HIV-1/*immunology
Interleukin-7/*immunology
Cells, Cultured ; Computer Simulation ; HIV Infections/pathology ; Humans ; Ki-67 Antigen/immunology